Pulmonary artery to aorta ratio for the detection of pulmonary hypertension: Cardiovascular magnetic resonance and invasive hemodynamics in heart failure with preserved ejection fraction

Background: previous work indicates that dilatation of the pulmonary artery (pa) itself or in relation to the ascending aorta (pa:ao ratio) predicts pulmonary hypertension (ph). whether these results also apply for heart failure with preserved ejection fraction (hfpef) is unknown. in the present study we evaluated the diagnostic and prognostic power of pa diameter and pa:ao ratio on top of right ventricular (rv) size,function,and septomarginal trabeculation (smt) thickness by cardiovascular magnetic resonance (cmr) in hfpef. methods and results: 159 consecutive hfpef patients were prospectively enrolled. of these,111 underwent cmr and invasive hemodynamic evaluation. by invasive assessment 64 % of patients suffered from moderate/severe ph (mean pulmonary artery pressure (mpap) ≥30 mmhg). significant differences between groups with and without moderate/severe ph were observed with respect to pa diameter (30.9 ± 5.1 mm versus 26 ± 5.1 mm,p < 0.001),pa:ao ratio (0.93 ± 0.16 versus 0.78 ± 0.14,p< 0.001),and smt diameter (4.6 ± 1.5 mm versus 3.8 ± 1.2 mm; p = 0.008). the strongest correlation with mpap was found for pa:ao ratio (r = 0.421,p < 0.001). by roc analysis the best cut-off for the detection of moderate/severe ph was found for a pa:ao ratio of 0.83. patients were followed for 22.0 ± 14.9 months. by kaplan meier analysis event-free survival was significantly worse in patients with a pa:ao ratio ≥ 0.83 (log rank,p = 0.004). by multivariable cox-regression analysis pa:ao ratio was independently associated with event-free survival (p = 0.003). conclusion: pa:ao ratio is an easily measureable noninvasive indicator for the presence and severity of ph in hfpef,and it is related with outcome. © 2015 karakus et al.